These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1111461

  • 1. Monitoring myelomatosis.
    Hobbs JR.
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [Abstract] [Full Text] [Related]

  • 2. Clinical classification of plasma cell myeloma.
    Conklin R, Alexanian R.
    Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
    [Abstract] [Full Text] [Related]

  • 3. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [Abstract] [Full Text] [Related]

  • 4. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W.
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [Abstract] [Full Text] [Related]

  • 5. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
    Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
    [No Abstract] [Full Text] [Related]

  • 6. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R, Migliore PJ.
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE, Pruzanski W.
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [Abstract] [Full Text] [Related]

  • 8. [Hypolipidemia in myeloma].
    Fiessinger JN, Ollier MP, Filitti-Wurmser S, Hartmann L.
    Ann Biol Clin (Paris); 1971 Jan; 29(1):25-37. PubMed ID: 4996178
    [No Abstract] [Full Text] [Related]

  • 9. Hypoalbuminemia in patients with multiple myeloma.
    Chen YH, Magalhaes MC.
    Arch Intern Med; 1990 Mar; 150(3):605-10. PubMed ID: 2310279
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y, Benbassat J, Polliack A.
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract] [Full Text] [Related]

  • 11. [Prognosis of multiple myeloma].
    Morell A, Skvaril F, Rüst HP, Spengler GA, Brunner K, Barandun S.
    Schweiz Med Wochenschr; 1970 Nov 14; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract] [Full Text] [Related]

  • 12. IV. Detection and differentiation of M-proteins by the acid-gel reaction--a re-evaluation.
    Daniels JC, Cobb EK, Levin WC, Ritzmann SE.
    Tex Rep Biol Med; 1970 Nov 14; 28(4):541-5. PubMed ID: 4995465
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B, Powles R, Kulkarni S, Rudin C, Saso R, Lal R, Singhal S, Mehta J, Horton C, Treleaven J.
    Bone Marrow Transplant; 2001 Jul 14; 28(1):29-37. PubMed ID: 11498741
    [Abstract] [Full Text] [Related]

  • 14. [2 new cases of initial or secondarily non-excreting plasma cell myelomas].
    Prost A, Soulilou JP, Gardais J, Hurez D, Cottin S.
    Rev Rhum Mal Osteoartic; 1973 Feb 14; 40(2):151-7. PubMed ID: 4574504
    [No Abstract] [Full Text] [Related]

  • 15. Multiple myeloma without initial paraproteins.
    Kim I, Harley JB, Weksler B.
    Am J Med Sci; 1972 Oct 14; 264(4):267-75. PubMed ID: 4630526
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.